Oppenheimer & Co’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,806
Closed -$381K 1670
2025
Q1
$381K Buy
+24,806
New +$389K 0.01% 1176
2024
Q4
Sell
-10,467
Closed -$171K 1621
2024
Q3
$171K Sell
10,467
-4,076
-28% -$69.8K ﹤0.01% 1421
2024
Q2
$274K Buy
14,543
+1,380
+10% +$26.7K ﹤0.01% 1224
2024
Q1
$259K Sell
13,163
-3,009
-19% -$60.8K ﹤0.01% 1237
2023
Q4
$330K Buy
16,172
+1,557
+11% +$30.7K 0.01% 1107
2023
Q3
$294K Buy
14,615
+584
+4% +$11.7K 0.01% 1136
2023
Q2
$273K Buy
14,031
+330
+2% +$6.21K 0.01% 1194
2023
Q1
$257K Sell
13,701
-4,008
-23% -$79.8K 0.01% 1176
2022
Q4
$365K Sell
17,709
-3,333
-16% -$67.1K 0.01% 1018
2022
Q3
$379K Sell
21,042
-5,334
-20% -$109K 0.01% 993
2022
Q2
$519K Buy
26,376
+2,334
+10% +$49.1K 0.01% 908
2022
Q1
$532K Sell
24,042
-6,477
-21% -$145K 0.01% 985
2021
Q4
$683K Buy
30,519
+11,527
+61% +$255K 0.01% 921
2021
Q3
$402K Buy
18,992
+14,133
+291% +$299K 0.01% 1103
2021
Q2
$98K Buy
4,859
+1,167
+32% +$23.4K ﹤0.01% 1472
2021
Q1
$68K Buy
+3,692
New +$66.4K ﹤0.01% 1413
2017
Q1
Sell
-4,983
Closed -$80K 1329
2016
Q4
$80K Sell
4,983
-84
-2% -$1.4K ﹤0.01% 1237
2016
Q3
$88K Hold
5,067
﹤0.01% 1224
2016
Q2
$74K Buy
5,067
+834
+20% +$12.8K ﹤0.01% 1180
2016
Q1
$64K Hold
4,233
﹤0.01% 1202
2015
Q4
$81K Hold
4,233
﹤0.01% 1224
2015
Q3
$78K Hold
4,233
﹤0.01% 1283
2015
Q2
$83K Buy
+4,233
New +$88.6K ﹤0.01% 1417
2015
Q1
Sell
-3,802
Closed -$91K 1527
2014
Q4
$91K Sell
3,802
-166
-4% -$4.29K ﹤0.01% 1337
2014
Q3
$109K Hold
3,968
﹤0.01% 1339
2014
Q2
$117K Sell
3,968
-2,920
-42% -$82.3K ﹤0.01% 1337
2014
Q1
$196K Sell
6,888
-645
-9% -$18.4K 0.01% 1250
2013
Q4
$209K Buy
7,533
+366
+5% +$10.8K 0.01% 1194
2013
Q3
$221K Sell
7,167
-1,000
-12% -$31.8K 0.01% 1108
2013
Q2
$256K Buy
+8,167
New +$261K 0.01% 994

Other funds holding OCSL

Oppenheimer & Co's OCSL Position: Q2 2025 in Review

Oppenheimer & Co sold out of Oaktree Specialty Lending (OCSL) in Q2 2025, closing a stake of 24,806 shares — an estimated $381K sold.

Oppenheimer & Co first reported a position in OCSL in Q2 2013 and held it in 30 quarters. The position peaked at $683K in Q4 2021. 193 funds tracked by Wall St. Rank hold OCSL as of Q2 2025.

  • Oppenheimer & Co reported no remaining Oaktree Specialty Lending position as of Q2 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 24,806 Oaktree Specialty Lending shares in Q2 2025, an estimated $381K.
  • Oppenheimer & Co first reported a position in Oaktree Specialty Lending in Q2 2013 and held it in 30 quarters.
  • Oppenheimer & Co's Oaktree Specialty Lending position peaked at $683K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q2 2025.

Based on Oppenheimer & Co's 13F filing for Q2 2025, filed 31 Jul 2025.